BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Harbin Medical University

Headquarters: Harbin, China
Year Founded: 1926
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Mar 8, 2024
Discovery & Translation

Distillery spotlight: new ubiquitin-modulating mechanisms from academia

Innovators are finding new ways of targeting E3 ligases and DUBs in liver diseases and cancer: BioCentury’s survey of the 2023 translational literature
BioCentury | Aug 14, 2023
Discovery & Translation

E3 ligase pathways for liver diseases, a trypanosome RPA1 inhibitor and more

New targets and compounds from BioCentury’s Distillery
BioCentury | Aug 11, 2023
Distillery Therapeutics

Increasing CAND1 activity for nonalcoholic fatty liver disease

BioCentury | Nov 22, 1993
Company News

AntiCancer deal

Items per page:
1 - 4 of 4
Help Center
Username
Request Training
Submit Data Correction
Ask a Question